Hanif, MuhammadNazarov, Alexey A.Legin, AntonGroessl, MichaelArion, Vladimir B.Jakupec, Michael A.Tsybin, Yury O.Dyson, Paul J.Keppler, Bernhard K.Hartinger, Christian G.2012-01-122012-01-122012-01-12201210.1039/c1cc14713ghttps://infoscience.epfl.ch/handle/20.500.14299/76568WOS:000298989800027Ru-II(arene) anticancer compounds with maleimide functionality were prepared to allow selective interaction with thiol-containing biomolecules and thereby enforcing the selective delivery of the compounds to the tumour.Compound Rapta-CIn-VitroComplexesDrugPapainCellsMaleimide-functionalised organoruthenium anticancer agents and their binding to thiol-containing biomoleculestext::journal::journal article::research article